• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Syncom Formulations (India) Limited

  • ID: 633078
  • April 2015
  • Region: India
  • 54 Pages
  • Wright Investors Service

A textual analysis of the financial results for Syncom Formulations (India) Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including contact information, senior officers and Wright Quality Rating analyses is also provided.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Syncom Formulations (India) Limited. There is a textual review of the financial results of Syncom Formulations (India) Limited versus Lyka Labs Limited, Mangalam Drugs & Organics Limited and Dil Limited. The comparative analysis of these companies READ MORE >

Note: Product cover images may vary from those shown

Company Fundamentals
- Company Profile
- Comparative Business Analysis
- Summary Analysis per Share
- Sales Analysis
- Price Analysis
- Earnings and Dividends Analysis

Financial Statement Analyses
- Balance Sheet - Common Size
- Balance Sheet - Year-Year Percent Change
- Balance Sheet - Five-Year Averages
- Income Statement - Common Size
- Income Statement - Year-Year Percent Change
- Income Statement - Five-Year Averages
- Sources of Capital

Financial Ratio Analyses
- Accounting Ratios
- Asset Utilization
- Employee Efficiency
- Fixed Charges Coverage
- Leverage Analysis
- Liquidity Analysis
- Per-Share Data
- Profitability Analysis

Wright Quality Rating Analyses
- Investment Acceptance
- Financial Strength
- Profitability and Stability
- Corporate Growth

Note: Product cover images may vary from those shown

India

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

  • Sagar Cements Limited - Product Thumbnail Image

    Sagar Cements Limited

    • Language: English
    • 54 Pages
    • Published: February 2015
    FROM
  • Fulford (India) Limited - Product Thumbnail Image

    Fulford (India) Limited

    • Language: English
    • 56 Pages
    • Published: December 2014
    • Region: India
  • Mangalam Timber Products Limited - Product Thumbnail Image

    Mangalam Timber Products Limited

    • Language: English
    • 53 Pages
    • Published: April 2015
    FROM
  • Syncom Healthcare Limited - Product Thumbnail Image

    Syncom Healthcare Limited

    • Language: English
    • 53 Pages
    • Published: March 2015
    FROM
  • Pharmesis International Ltd - Product Thumbnail Image

    Pharmesis International Ltd

    • Language: English
    • 55 Pages
    • Published: March 2015
    • Region: Global
    FROM
  • Dil Limited - Product Thumbnail Image

    Dil Limited

    • Language: English
    • 55 Pages
    • Published: April 2015
    FROM
  • Sanghi Industries Limited - Product Thumbnail Image

    Sanghi Industries Limited

    • Language: English
    • 53 Pages
    • Published: April 2015
    FROM
  • Mangalam Drugs & Organics Limited - Product Thumbnail Image

    Mangalam Drugs & Organics Limited

    • Language: English
    • 55 Pages
    • Published: April 2015
    FROM
  • Lyka Labs Limited - Product Thumbnail Image

    Lyka Labs Limited

    • Language: English
    • 54 Pages
    • Published: April 2015
    FROM
  • Gufic Biosciences Ltd - Product Thumbnail Image

    Gufic Biosciences Ltd

    • Language: English
    • 54 Pages
    • Published: April 2015
    FROM

Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.